Evidence map›Paper›PMID 26385167›Full record

ArticleJournal of controlled release : official journal of the Controlled Release Society2015

Alpha-2-macroglobulin loaded microcapsules enhance human leukocyte functions and innate immune response.

Donata Federici Canova, Anton M Pavlov, Lucy V Norling, Thomas Gobbetti, Sandra Brunelleschi, Pauline Le Fauder, Nicolas Cenac, Gleb B Sukhorukov, Mauro Perretti

Open access · hybridAbstract read
In one paragraph

Article in Journal of controlled release : official journal of the Controlled Release Society, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. IL-34 Actions on FOXP3Frontiers in immunology · 2020
    Article
  8. Differential protein expression in patients with urosepsis.Chinese journal of traumatology = Zhonghua chuang shang za zhi · 2018
    Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 4 countries.

Donata Federici CanovaWilliam Harvey Research Institute, Barts and the London School of Medicine, Queen Mary University of London, London, United Kingdom.
Anton M PavlovSchool of Engineering & Materials Science, Queen Mary University of London, London, United Kingdom; Saratov State University, Saratov, Russia.
Lucy V NorlingWilliam Harvey Research Institute, Barts and the London School of Medicine, Queen Mary University of London, London, United Kingdom.
Thomas GobbettiWilliam Harvey Research Institute, Barts and the London School of Medicine, Queen Mary University of London, London, United Kingdom.
Sandra BrunelleschiDepartment of Health Science, University of Eastern Piedmont, Novara, Italy.
Pauline Le FauderMetaToul Lipidomics Facility, INSERM UMR1048, Toulouse, France.
Nicolas CenacINSERM UMR1043, Université Toulouse III Paul-Sabatier, Toulouse, France.
Gleb B SukhorukovSchool of Engineering & Materials Science, Queen Mary University of London, London, United Kingdom.
Mauro PerrettiWilliam Harvey Research Institute, Barts and the London School of Medicine, Queen Mary University of London, London, United Kingdom. Electronic address: m.perretti@qmul.ac.uk.
Queen Mary University of London · GBInserm · FRWilliam Harvey Research Institute · GBSaratov State University · RUUniversità degli Studi del Piemonte Orientale “Amedeo Avogadro” · IT

Funding

Arthritis Research UK 19909Biotechnology and Biological Sciences Research Council BB/J001473/1
6 · The paper itself

Abstract

Synthetic microstructures can be engineered to deliver bioactive compounds impacting on their pharmacokinetics and pharmacodynamics. Herein, we applied dextran-based layer-by-layer (LbL) microcapsules to deliver alpha-2-macroglobulin (α2MG), a protein with modulatory properties in inflammation. Extending recent observations made with dextran-microcapsules loaded with α2MG in experimental sepsis, we focused on the physical and chemical characteristics of these microstructures and determined their biology on rodent and human cells. We report an efficient encapsulation of α2MG into microcapsules, which enhanced i) human leukocyte recruitment to inflamed endothelium and ii) human macrophage phagocytosis: in both settings microcapsules were more effective than soluble α2MG or empty microcapsules (devoid of active protein). Translation of these findings revealed that intravenous administration of α2MG-microcapsules (but not empty microcapsules) promoted neutrophil migration into peritoneal exudates and augmented macrophage phagocytic functions, the latter response being associated with alteration of bioactive lipid mediators as assessed by mass spectrometry. The present study indicates that microencapsulation can be an effective strategy to harness the complex biology of α2MG with enhancing outcomes on fundamental processes of the innate immune response paving the way to potential future development in the control of sepsis.

Indexed as

alpha-MacroglobulinsAnimalsCapsulesCells, CulturedDextransDrug CompoundingHumansHuman Umbilical Vein Endothelial CellsImmunity, InnateLeukocytesMacrophagesMaleMice, Inbred C57BLA2M protein, humanalpha-MacroglobulinsCapsulesDextransAlpha-2-macroglobulinInflammationLbL microcapsulesLeukocyte activationPhagocytosis

Identifiers

PMID26385167
PMCPMC4649706
OpenAlexW1889187625

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.